Equibles does not estimate personal net worth.
Get an email with a short summary when Ionis Pharmaceuticals Inc publishes a filing, an earnings call transcript or a press release.
Get IONS alertsBeth Hougen is recorded as CFO at Ionis Pharmaceuticals Inc (IONS). Beth Hougen has spoken on 19 earnings calls across 1 company, most recently for Ionis Pharmaceuticals Inc on July 29, 2026. Ionis Pharmaceuticals Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Ionis Pharmaceuticals Inc includes Brett Monia (CEO), Elizabeth Hougen (CFO), Patrick R. O’Neil (General Counsel) and 5 others.
“We delivered strong financial results in the first half of this year, supported by increased revenue from our commercial medicines and meaningful R&D revenue from our partnered programs, while we've continued to invest in our long-term growth.”
“2025 was a defining year for IONUS across our business, resulting in our impressive financial performance. We exceeded our guidance across all metrics through exceptional execution and disciplined financial management.”
“We delivered another strong quarter driven by continued commercial execution and disciplined financial management, which enables us to raise our financial guidance once again.”
“I am pleased to share today that we are increasing our 2025 financial guidance across all metrics, including raising revenue by more than 20% due to our strong first quarter results and recent successful licensing transactions.”
“We've made excellent progress advancing our strategic growth priorities, including executing our first independent launch while simultaneously upholding our commitment to drive operating leverage.”
Biotechnology · Healthcare
CFO
